Blood Cancer Update: New Insights for the Future

Edward A. Stadtmauer, MD, Section Chief for Hematological Malignancies at the Abramson Cancer Center offers a comprehensive update on recent advances in the diagnosis, treatment and clinical research for the hematologic malignancies, including multiple myeloma, the acute and chronic myeloid and lymphocytic leukemias, Hodgkin and non-­Hodgkin lymphoma and mantle cell lymphoma. Dr. Stadtmauer’s discussion includes an overview of clinical research, novel drug therapies-­­including ibrutinib­­-and a review of integrated mutational profiling and its value.